BROWNSBURG, Ind., May 23, 2013 /PRNewswire/ -- Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., a global leader in human cord blood stem cell banking and therapeutics, announced today that StemCyte has become an associate sponsor of the No. 16 Acorn Stairlifts Indy car driven by James Jakes . Sponsorship is for the remainder of the IZOD IndyCar 2013 season.
StemCyte, Inc. and Rahal Letterman Lanigan Racing (RLL) will work to support awareness of umbilical cord blood banking and its educational initiative 'Stars for Stem Cells'. Cord blood stem cells are potential cures for over 80 illnesses, including cancers, blood disorders, immune and genetic diseases, and continue be a key element in regenerative medicine research.
"We are very excited about our relationship with Rahal Letterman Lanigan Racing," said Calvin Cole , StemCyte President for Commercial Operations, North America. "We believe StemCyte's brand aligns with the pioneering image of IndyCar and the championship spirit of Bobby Rahal . Supporting driver James Jakes and getting the word out on options for expecting parents to secure their baby's cord blood for future life-saving treatments is very important."
"We are always looking towards innovation in our ongoing efforts within the world of motorsports," said Bobby Rahal , co-owner of Rahal Letterman Lanigan Racing with CBS LATE SHOW host David Letterman and Mi-Jack co-owner Mike Lanigan . "Working with StemCyte to promote awareness of cord blood banking, and the incredible medical research that can advance future healthcare, keeps all of us on the leading edge."
"As drivers we take lots of risk
|SOURCE StemCyte, Inc.|
Copyright©2012 PR Newswire.
All rights reserved